Concepedia

W. Jens Zeller

WJ

Statistics

Publications

22

Citations

673

H-Index

17

Active since

1937

Affiliations

German Cancer Research Center(Current)

Heidelberg University

University Hospital Heidelberg

University Medical Centre Mannheim

Paracelsus-Kliniken

W. Jens Zeller is an author at German Cancer Research Center specializing in medicine, oncology, and pharmacology.

Publications per year

1937–2013

22

Publications

22

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG

Aleksandar Radujkovic, M Schad, Julian Topaly et al. · Leukemia · 2005 · 92 citations

Medicine, Oncology, Pharmacology +6

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL<sup>+</sup>cell to Imatinib and Nilotinib

Falk Dillmann, Marlon R. Veldwijk, Stephanie Laufs et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 63 citations

Medicine, Oncology, Pharmacology +13

The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer

Doreen Heckmann, Patrick Maier, Stephanie Laufs et al. · Clinical Cancer Research · 2013 · 48 citations · Full text

Medicine, Cell Biology, Oncology +15

Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood

Murat Aktas, Anja Buchheiser, Amelie Pia Houben et al. · Cytotherapy · 2010 · 46 citations

Life Sciences, Biotechnology, Cell Biology +16

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

Julian Topaly, Stefan Früehauf, Anthony D. Ho et al. · British Journal of Cancer · 2002 · 43 citations · Full text

Medicine, Hematology, Pharmacology +14

1–5 of 22